3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Burkitt Lymphoma
9
Precursor Cell Lymphoblastic Leukemia-Lymphoma
6
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
4
Leukemia
3
Recurrence
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma
1
Leukemia, Biphenotypic, Acute
1
Interventions
fludarabine
4
Cyclophosphamide
4
fludarabine phosphate
3
Melphalan
3
pembrolizumab
2
obinutuzumab
2
blinatumomab
2
Rituximab
2
Radiotherapy
2
Lenalidomide
2
Capecitabine
2
Blood Specimen Collection
2
trastuzumab deruxtecan
1
tislelizumab
1
tisagenlecleucel
1
thymoglobulin
1
tetrathiomolybdate
1
talquetamab
1
sacituzumab govitecan
1
relugolix
1
palbociclib
1
nilotinib
1
isatuximab
1
inavolisib
1
giredestrant
1
enzalutamide
1
avelumab
1
atezolizumab
1
acalabrutinib
1
abemaciclib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neoplasm, Residual
×
Inotuzumab Ozogamicin
×
90 days
×
Clear all
No trials found.